INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...

KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...

Experiments, robots and demonstrations filled the gym at Summit Academy Charter School in Red Hook, where students became teachers and scientists during a new day-long ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

The Free Software Foundation (FSF), a Massachusetts 501 (c) (3) charity with a worldwide mission to promote computer user freedom, seeks a motivated and talented individual to be our new Engineering ...

You’ve seen people sliding into the tube of a magnetic resonance imaging (MRI) machine on your favorite medical drama, or maybe you’ve been inside one yourself, waiting as the noisy scanner makes ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...

Stephen Hawking's black hole fame wasn't his only focus — he also laid out multiple existential threats. Here are five doomsday risks he talked about.

The Pershing Square Foundation today announced the eight winners of the "MIND" Prize (Maximizing Innovation in Neuroscience Discovery). Through the Prize, the Foundation strives to change the paradigm ...

Stylus Medicine, a member of BioSpace’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from ...

Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency.